Funding for this research was provided by:
National Institute of Health
National Institute of Allergy and Infectious Diseases
Received: 14 May 2019
Accepted: 12 August 2019
First Online: 18 September 2019
Change Date: 22 October 2019
Change Type: Correction
Change Details: After publication of the original article , we were notified in Table 1 a column should be removed.
Ethics approval and consent to participate
: Prior to participation in the study the patient signed Mater Misericordiae University Hospital ID Cohort Project consent form. This form is used by our research centre as a means to invite patients to take part in research to monitor long term infectious disease, in particular HIV. This lady was informed about Elite Control and the reason we had particular interest in her case. She was invited to attend clinic for further blood tests, clinical assessment with view to use in research and publication. She was informed of risks of participating in this study (in particular blood sampling).She was aware that participation was entirely voluntary and that she was free to withdraw consent and discontinue participation at any time. This consent form is available on request.
: Written consent was obtained using the BMC Central Consent to Publish Form and is available on request from the Editor.
: Timothy J. Henrich receives grant support from Gilead Sciences and provided consulting for Merck and Co. Vitalant Research Institute receives research grant support from Hologic related to application of replicate Aptima HIV viral load testing to quantify low level plasma viremia.